Key result
Prognostic biomarkers and imaging remain vital for monitoring CAD progression and optimizing treatment plans.
Why the study?
A lack of cost-effective strategies for monitoring CAD prognosis creates a need to identify key biomarkers and imaging markers among over 1,000 candidates to assess disease severity, progression, and treatment efficacy.
Design
Literature review
Authors
Loading...
Supports biomarker-guided CAD monitoring; leaves open prospective validation of optimal markers before routine adoption.
Utilizing key prognostic biomarkers and imaging techniques can improve patient care, optimize treatment plans, and reduce healthcare costs associated with CAD management.
Yazdani et al. (2023) conducted a review in Coronary Artery Disease (CAD). Biomarkers and imaging techniques was evaluated. Prognostic biomarkers and imaging techniques play a vital role in monitoring coronary artery disease progression and evaluating therapeutic interventions to optimize treatment plans.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: